Dbl Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
DBL (also known as MCF2) is the founding member of the Dbl family of Rho guanine nucleotide exchange factors (RhoGEFs). The protein was originally identified as an oncogene from a diffuse B-cell lymphoma and encodes a specific activator of Rho GTPases. DBL catalyzes the exchange of GDP for GTP on Rho GTPases, thereby activating them.
Dbl Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
DBL (also known as MCF2) is the founding member of the Dbl family of Rho guanine nucleotide exchange factors (RhoGEFs). The protein was originally identified as an oncogene from a diffuse B-cell lymphoma and encodes a specific activator of Rho GTPases. DBL catalyzes the exchange of GDP for GTP on Rho GTPases, thereby activating them.
The study of Dbl Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Unknown, DBL family Rho guanine nucleotide exchange factors (2018) (2018)](https://doi.org/10.1002/cphy.170100)
[Unknown, Rho signaling in neuronal development (2019) (2019)](https://doi.org/10.1016/j.neuron.2019.04.015)
[Unknown, DBL in actin cytoskeleton regulation (2020) (2020)](https://doi.org/10.1016/j.tcb.2020.08.002)